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INTRODUCTION:  Hepatocellular  carcinoma  (HCC)  is  one  of the  most  common  cancers  worldwide,  the
incidence  of  which  parallels  that of  areas  with  high  prevalence  of chronic  hepatitis.  HCC  commonly
metastasizes  to the  lungs,  lymph  nodes,  adrenals  and  bones  with  the overall  prognosis  of  metastatic  HCC
being  dismal.
PRESENTATION  OF  CASE:  We  herein  with  present  a case  of  a 70-year-old  male  who  was  referred  to  our  insti-
tution  with  history  of nasal  obstruction  and nasal  bleeding  which  on  further  evaluation  was  diagnosed
to  have  an  isolated  metastasis  to nasopharynx  from  liver  primary.
DISCUSSION: Extrahepatic  metastasis  in  HCC  occurs  in about  30–50%  of  patients,  the  commonest  site
being  the  lung.  Rare  sites  of  extrahepatic  metastasis  from  HCC  to  the ovaries,  kidneys,  skeletal  and  cardiacetastasis musculature  and  brain  have  been  reported.  Unusual  sites  of  metastasis  in  the head  and  neck  area  like
the  mandible  have  also  been  documented.  With  the  changing  trends  in  the  treatment  modalities,  these
patients  are  often  treated  using  target  therapy.
CONCLUSION: This  article  presents  an  unusual  isolated  metastasis  to nasopharynx  from  HCC  in the  absence
of  disseminated  disease.  This case  report  illustrates  the  distinctive  pathological  features  of  metastatic
HCC.
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. Introduction
Hepatocellular carcinoma (HCC) ranks amongst one of the most
ommon types of cancers worldwide. This cancer is more common
n South East Asian countries where hepatitis B and C infections are
he usual predisposing factors. The disease generally manifests in
he 6th and 7th decade of life. Most cases come into clinical picture
Open access under CC BY-NC-Nt an advanced stage minimizing the chance of cure. HCC commonly
preads to the lungs, peritoneum, adrenal glands and bones.1
xtra-hepatic metastasis at ﬁrst presentation, although
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uncommon, is frequently recognized as advanced disease with a
poor prognosis.
2.  Case details
A  70-year-old male with no comorbidities presented with his-
tory of recurrent nasal obstruction and nasal discharge since 6
months and bleeding through the nose since 15 days. There was
no ear pain or hoarseness of voice. Patient was a known smoker
and alcoholic since 40 years. Patient was  evaluated elsewhere
with nasopharyngoscopy and biopsy and was then referred to us.
Systemic examination was  normal. Head and neck examination
including nasopharyngoscopy was  normal.
Biopsy from the nasopharynx that was  done outside revealed
moderately differentiated adenocarcinoma (Figs. 1 and 2). IHC done
at our hospital showed that the cells were positive for Glypican-3,
AFP, CK, Hepar-1 and CK 7 (occasional) and were negative for CK 20
that suggested metastatic hepatocellular carcinoma (Figs. 3 and 4).
Hence a PET-CT scan was  done which showed cirrhosis of liver
with signs of portal hypertension in the form of splenomegaly and
multiple porto-systemic collaterals, a 1.9 cm × 1.2 cm ill-deﬁned
hypodense focal lesion in liver and minimal ascites (Fig. 5). There
was no metabolic activity or an obvious mass in the region of
se.nasopharynx (Fig. 6). Serum AFP was >10,000 IU/l.
USG  guided FNAC of the liver lesion showed only sheets of
benign liver cells. The patient however, refused further CT guided
biopsy.
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Fig. 1. Low power view.
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Fig. 4. IHC-AFP positivity.Fig. 2. High power view showing hepatocytes.
The patient was advised radiation to the nasopharynx and target
herapy for the liver lesion but patient refused treatment..  Discussion
Extrahepatic metastasis of HCC occurs in about 30–50% of
atients,1 and it depends on HCC stages. The commonest site
Fig. 3. IHC-Hepar-1 positivity.Fig. 5. Metabolically active SOL in liver.
of extra-hepatic metastasis is the lung. In a study by Sawabe
et al.,2 extrahepatic metastases of HCC was found in 64% of the
98 autopsies conducted and most of them (97%) were pulmonary
metastases. Katyal et al.3 found extrahepatic metastasis in 148
(32%) of the 463 patients with HCC. The most common sites were
lung (55%), lymph nodes (41%), bones (28%), adrenals (11%) and
peritoneal deposits (11%). In another study by Natsuizaka et al.,4
65 (13%) of the 482 patients with HCC had extrahepatic metastases.
Fig. 6. No obvious mass in nasopharynx.
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he most common location was lung followed by bone and lymph
odes.
The pathological diagnosis of metastatic HCC at extrahepatic
ites can be made by demonstrating acidophilic cells in trabecu-
ar and pseudo-glandular patterns. Detection of bile and mallory
odies strongly suggests HCC.1 Immunohistochemical studies are
f great value. HepPar1 is a relatively speciﬁc marker of hepato-
ytes and HCC.5 AFP is also a speciﬁc marker of HCC. Cytokeratins
 and 18 are hepatocyte cytokeratins which are also expressed in
ther tumors.1
Rare sites of metastasis from HCC to the ovaries,6,7 kidneys,8
uscles,9 brain10 and heart11 have been documented. An isolated
andibular metastasis has been reported from a locally advanced
CC.12
In this part of the subcontinent, advanced HCC is a common
resentation with poor prognosis. The median survival time from
iagnosis to end point is 4–7 months.11
HCC is historically a chemo and radioresistant tumour. The treat-
ent of metastatic HCC involves the use of targeted agents like
orafenib. To the best of our knowledge, this is the ﬁrst case report
f an isolated nasopharyngeal metastasis at presentation from a
iver primary.
.  Conclusion
HCC metastasizing to the nasopharynx is extremely rare. Treat-
ent involves addressing the nasopharynx with radiation and the
iver primary with targeted therapy.
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